COMMUNIQUÉS West-GlobeNewswire
-
Dyadic Applied BioSolutions Announces Participation in Sidoti Virtual Investor Conference
19/05/2026 -
TOMI™ Environmental Solutions Mobilizes SteraMist iHP Technology in Response to Emerging Global Pathogen Threats
19/05/2026 -
Edesa Biotech to Present New Data on Paridiprubart in Acute Kidney Injury at European Nephrology Conference
19/05/2026 -
Curia Completes Upgrade of API Aseptic Suites in Valladolid, Spain
19/05/2026 -
Joshua Fritzler Named President of Olympia and Wesley Pharmaceuticals
19/05/2026 -
SafeSpace Global Corp. (OTCID: SSGC) to Present at the Sidoti Micro-Cap Virtual Conference on May 21st
19/05/2026 -
dacadoo and Bradesco Vida e Previdência Partner to Bring Digital Health Engagement to Millions in Brazil
19/05/2026 -
Nord Pilates Surpasses 1,300 Customer Reviews as Women Praise Personalized Pilates Plans and Low-Impact Home Workouts
19/05/2026 -
Enspire Dental Launches New Emergency Care Initiative to Assist Ann Arbor Families During Dental Crises
19/05/2026 -
Curia achève la modernisation de ses unités aseptiques de fabrication d’API à Valladolid, en Espagne
19/05/2026 -
BioSyent annonce l’approbation de Thyconvi(MD) par Santé Canada (solution orale de lévothyroxine)
19/05/2026 -
Capra Biosciences Launches Bioproduced Salicylic Acid for Personal Care at NYSCC Suppliers’ Day
19/05/2026 -
Resmed and ŌURA Partner to Expand Access to Sleep Health Education and Care
19/05/2026 -
ENvue Medical to Showcase ENvue™ Navigation Platform at AACN NTI 2026
19/05/2026 -
NeOnc Technologies Gains Growing Institutional Support Ahead of Key Brain Cancer Clinical Milestones
19/05/2026 -
OKYO Expands Scientific Advisory Board with the Appointment of International Expert Marta Sacchetti, MD, PhD
19/05/2026 -
Propanc Biopharma Engages European CDMO for GMP Production of PRP for Phase 1b, FIH Study in 30 – 40 Advanced Cancer Patients
19/05/2026 -
Tiziana Announces New Positive Clinical Data for Intranasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis
19/05/2026 -
Amplia Therapeutics Launches First Stage of Registration-Enabling Trial of Narmafotinib
19/05/2026
Pages